Table 2.
Visual Function and Corneal Health Status Questionnaire
| Netarsudil QD (n = 20) | Netarsudil BID (n = 20) | |
|---|---|---|
| Visual Acuity Factor Score, mean ± SEM | ||
| Baseline score | 1.07 ± 0.1 | 0.67 ± 0.15 | 
| Change from baseline | ||
| Week 4 | −0.39 ± 0.13 (P = 0.0058)* | −0.14 ± 0.12 (P = 0.2252) | 
| Week 8 | −0.34 ± 0.12 (P = 0.0121)* | −0.24 ± 0.13 (P = 0.0407)* | 
| Glare Factor and Diurnal Variation Score, mean ± SEM | ||
| Baseline score | 0.72 ± 0.09 | 0.38 ± 0.12 | 
| Change from baseline | ||
| Week 4 | −0.28 ± 0.11 (P = 0.0148)* | 0.04 ± 0.08 (P = 0.6300) | 
| Week 8 | −0.29 ± 0.11 (P = 0.0200)* | −0.02 ± 0.10 (P = 0.9472) | 
Statistically significant at 5% level. P values based on one-sample t-test for within-group comparisons to baseline.
SEM, standard error of mean.